After osteoarthritis, Fibromyalgia is the most prevalent rheumatic disease, affecting millions of people worldwide. Between 2–8% of the US population live with the disorder, their lives greatly burdened by the chronic condition's deep and widespread pain, fatigue, cognitive impairments, and sleep difficulties.

While there is no cure, effective treatment can control symptoms. The Lumina Fibromyalgia Program presents a guide that healthcare providers can use to better understand, diagnose, and treat the often misdiagnosed and greatly misunderstood chronic widespread pain condition. The 20 hour self-directed online learning course is a cornerstone of this program.